Showing 1 - 10 of 114
sales price of a developed innovation. This will trigger preemptive acquisitions by incumbents, thus increasing the reward …
Persistent link: https://www.econbiz.de/10005025461
' signaling-driven investment, despite the risk of buying a bad innovation. We finally show at what point the presence of active …
Persistent link: https://www.econbiz.de/10005419514
The starting point of this paper is that the exit of venture-backed firms often takes place through sales to large incumbent firms. We show that in such an environment, venture-backed firms have a stronger incentive to develop basic innovations into commercialized innovations than incumbent...
Persistent link: https://www.econbiz.de/10005645429
No abstract.
Persistent link: https://www.econbiz.de/10010684521
No abstract.
Persistent link: https://www.econbiz.de/10010684540
Entrepreneurs face higher commercialization costs than incumbents. We show that this implies that entrepreneurs will choose more risky projects than incumbents, aiming to reduce their high expected marginal commercialization cost. However, entrepreneurs may select too safe projects from a social...
Persistent link: https://www.econbiz.de/10010818447
Market competition is central to innovative activity, the diffusion process and macro-economic productivity growth. Productivity growth at all levels comes about through institutional reconfiguration in response to the ongoing market process. Stable and sustained long-term growth in output...
Persistent link: https://www.econbiz.de/10010818448
No abstract.
Persistent link: https://www.econbiz.de/10010818474
We develop a theory of commercialization mode (entry or sale) of entrepreneurial inventions into oligopoly, and show that an invention of higher quality is more likely to be sold (or licensed) to an incumbent due to strategic product market effects on the sales price. Moreover, preemptive...
Persistent link: https://www.econbiz.de/10004964394
State subsidies to R & D or innovative investments in firms are organized in many different ways. Examples from the plethora of extant subsidy instruments are tax incentives, grants to researchers, project grants, loans, conditional loans, and grants with royalty rights. Very little is currently...
Persistent link: https://www.econbiz.de/10011019052